APA (7th ed.) Citation

You, W., Ma, X., Xu, Y., Jin, X., Mao, W., Ji, M., . . . Wu, X. (2026). Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or INOCA Related to Culprit Vessels in Diabetic Patients With STEMI After DCB Therapy During Long‐Term Follow‐Up. Journal of Diabetes, 18(2), 1. https://doi.org/10.1111/1753-0407.70197

Chicago Style (17th ed.) Citation

You, Wei, et al. "Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or INOCA Related to Culprit Vessels in Diabetic Patients With STEMI After DCB Therapy During Long‐Term Follow‐Up." Journal of Diabetes 18, no. 2 (2026): 1. https://doi.org/10.1111/1753-0407.70197.

MLA (9th ed.) Citation

You, Wei, et al. "Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or INOCA Related to Culprit Vessels in Diabetic Patients With STEMI After DCB Therapy During Long‐Term Follow‐Up." Journal of Diabetes, vol. 18, no. 2, 2026, p. 1, https://doi.org/10.1111/1753-0407.70197.